Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Current Advances in the Antimicrobial Potential of Species of Genus Ganoderma (Higher Basidiomycetes) against Human Pathogenic Microorganisms

Full text
Author(s):
Rai, Mahendra [1] ; Gaikwad, Swapnil [1] ; Nagaonkar, Dipali [1] ; dos Santos, Carolina Alves [2]
Total Authors: 4
Affiliation:
[1] SGB Amravati Univ, Dept Biotechnol, Amravati 444602, Maharashtra - India
[2] Univ Sorocaba UNISO, Lab Biomat & Nanotecnhol, Sorocaba, SP - Brazil
Total Affiliations: 2
Document type: Review article
Source: International Journal of Medicinal Mushrooms; v. 17, n. 10, p. 921-932, 2015.
Web of Science Citations: 13
Abstract

Ganoderma spp. are very important therapeutic mushrooms and have been used traditionally for 4000 years in the treatment of various human disorders. Different species of Ganoderma possess bioactive compounds, which have already demonstrated antiviral, antibacterial, and antifungal activities. Various bioactive compounds such as triterpenoids, colossolactones, and polysaccharides, which are responsible for the antimicrobial potential of the genus, are discussed here in detail. Some Ganoderma spp. have been reported to be potential agents for the synthesis of metal nanoparticles. These nanoparticles have demonstrated antimicrobial activity and also are reviewed herein. The main aim of this review is to discuss the possible use of Ganoderma extracts and their active principles in antimicrobial therapy. (AU)

FAPESP's process: 12/03731-3 - Biosynthesis of silver nanoparticles by selected species of Phoma and their activity against multi-drug resistant microbes
Grantee:Nelson Eduardo Duran Caballero
Support Opportunities: Research Grants - Visiting Researcher Grant - International